EGFR and non-small cell lung carcinoma: Mutations in the EGFR gene, particularly those occurring in the kinase domain, are frequently observed in various malignancies—including non-small cell lung cancer (NSCLC) and glioblastoma [2,3], where they often act as key oncogenic drivers.